Neal S. Kleiman

Showing 1-1 of 1 articles

Interventions for valvular disease

One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial

Serruys P, Modolo R, Reardon M, Miyazaki Y, Windecker S, Popma J, Chang Y, Kleiman NS, Lilly S, Amrane H, Boonstra P, Kappetein A, Onuma Y, Søndergaard L, Van Mieghem N

October 19, 2018 | 10.4244/EIJ-D-18-00460

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Ahead of Print: OCT findings in ESR

Jincheng Guo et al.

February 24, 2021

Consolidating the value of the standardised ARC-HBR definition

Giuseppe Gargiulo et al.

February 24, 2021

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

This weeks JAA's: IVUS Guidewire Locations During Retrograde CTO, TF-TAVI endovascular closing and more..

February 16, 2021

European position paper on PFO – Part II

Christian Pristipino et al.

January 28, 2021

Valvular disease